Journal article
Utility of the ACC/AHA lesion classification as a predictor of procedural, 30-day and 12-month outcomes in the contemporary percutaneous coronary intervention era
J Theuerle, MB Yudi, O Farouque, N Andrianopoulos, P Scott, AE Ajani, A Brennan, SJ Duffy, CM Reid, DJ Clark
Catheterization and Cardiovascular Interventions | WILEY | Published : 2018
DOI: 10.1002/ccd.27411
Abstract
Background: Correlations between the ACC/AHA coronary lesion classification and clinical outcomes in the contemporary percutaneous coronary intervention (PCI) era are not well established. Methods: We analyzed clinical characteristics and outcomes according to ACC/AHA lesion classification (A, B1, B2, C) in 13,701 consecutive patients from the Melbourne Interventional Group (MIG) registry. Patients presenting with STEMI, cardiogenic shock and out-of-hospital cardiac arrest were excluded. The primary endpoints were 30-day and 12-month mortality. Secondary endpoints were procedural success as well as 30-day and 12-month major adverse cardiac events. Results: Of the 13,701 patients treated, 1,2..
View full abstractGrants
Awarded by Pfizer
Funding Acknowledgements
The Melbourne Interventional Group acknowledges unrestricted educational grant funding from: Abbott Vascular, Astra-Zeneca, Medtronic, MSD, Pfizer, Servier, and The Medicines Company. These companies do not have access to the data, and do not have the right to review manuscripts before publication.